Form D · Other Technology
Funga PBC
Austin, TX · CIK 0001960699
Offering snapshot reported Dec 5, 2024 · SEC filing
- Reported sold
- $5.06M Offering amount: $5.06M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 3, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 5, 2024 | Initial | $5,056,875 | No comparison | 8 | SEC filing |
| Jan 5, 2023 | Initial | $4,038,267 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-531179
Source: Form D, filed Dec 5, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Colin Averill | Director, Executive |
| Matthew Nordan | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
813 Springdale Road
Austin, TX, 78702
Austin, TX, 78702